← FDA Drug Approvals (Drugs@FDA)

REPAGLINIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2023-03-22

Drug application

FDA Application #

ANDA207209

Application type

Abbreviated New Drug Application (Generic)

Brand name

REPAGLINIDE

Generic name

REPAGLINIDE

Active ingredients

REPAGLINIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MACLEODS PHARMS LTD

Manufacturer

Macleods Pharmaceuticals Limited

First approval

2023-03-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown